Top Markets
Coin of the day
Glenmark Life Sciences Limited Glenmark Life Sciences Limited

Glenmark Life Sciences Limited

GLS
Rankning i aktier #7700
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011,... Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
Aktiekurs
$12.18
Senast synkroniserad: 2025-02-17
Marknadsvärde
$1.49B
Förändring (1 dag)
4.21%
Förändring (1 år)
0.00%
Land
IN
Handel Glenmark Life Sciences Limited (GLS)

Kategori

Aktiekurshistorik för Glenmark Life Sciences Limited (GLS)
Högsta slutkurs: $13.07 den 2025-02-01

Lägsta slutkurs: $9.63 den 2021-08-01
Aktiekurshistorik för Glenmark Life Sciences Limited från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2025 8.46%
2024 56.27%
2023 49.21%
2022 -36.04%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$171.67 -
DE
$165.82 32.07%
DE
$37.84 25.57%
JP
$223.44 28.17%
CH
$21.19 17.04%
IN